Publication

Randomized phase III trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU): GRID trial

Casali, P
; 
Reichardt, P
; 
Kang, Y
; 
Blay, J
; 
Joensuu, H
; 
Maki, R
; 
Rutkowski, P
; 
Hohenberger, P
; 
Gelderblom, H
; 
Leahy, Michael G
... show 10 more
Citations
Altmetric:
Abstract
Authors
Casali, P
Reichardt, P
Kang, Y
Blay, J
Joensuu, H
Maki, R
Rutkowski, P
Hohenberger, P
Gelderblom, H
Leahy, Michael G
von Mehren, M
Schoffski, P
Blackstein, M
Le Cesne, A
Badalamenti, G
Xu, J
Nishida, T
Laurent, D
Kuss, I
Demetri, G
Affiliation
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Description
Date
2015
Publisher
Collections
All Christie Publications
Show all metadata
Keywords
Type
Meetings and Proceedings
Citation
Randomized phase III trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU): GRID trial. 2015, 26 (Suppl 6): 29 Ann Oncol
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/592950
Embedded videos